Log In
BCIQ
Print this Print this
 

HA-Irinotecan

Also known as: HyCAMP

  Manage Alerts
Collapse Summary General Information
Company Alchemia Ltd.
DescriptionIV formulation of irinotecan and hyaluronic acid developed using HyACT technology
Molecular Target Topoisomerase I (TOP1)
Mechanism of ActionTopoisomerase I inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/01/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today